Autolus Therapeutics (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.34

-0.07 (-4.96%)

At close: May 01, 2025, 3:59 PM

1.36

1.12%

After-hours: May 01, 2025, 07:50 PM EDT

Autolus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Revenue	10.12M	1.7M	6.19M	2.33M	242K	2.91M	1.05M	1.69M	1.21M
Cost of Revenue	11.39M	6.57M	137.22M	128.65M	134.89M	4.61M	48.3M	1.01M	478K
Gross Profit	-1.27M	-4.87M	-131.03M	-126.32M	-134.65M	-1.7M	-47.25M	684K	734K
Operating Income	-241.43M	-195.03M	-163.78M	-164.21M	-168.15M	-137.86M	-57.53M	-23.42M	-14.38M
Interest Income	32.35M	13.51M	1.71M	262K	536K	2.54M	4.12M	84K	75K
Pretax Income	-219.13M	-208.4M	-173.21M	-165.99M	-166.26M	-139.01M	-36.33M	-23.38M	-14.33M
Net Income	-220.66M	-208.38M	-148.84M	-142.1M	-142.09M	-123.85M	-31.11M	-19.73M	-12.55M
Selling & General & Admin	101.09M	46.74M	31.9M	31.86M	34.97M	39.45M	16.85M	9.1M	5.15M
Research & Development	138.44M	149.98M	141.99M	134.79M	134.89M	105.42M	24.64M	16.01M	10.44M
Other Expenses	637K	n/a	-166K	-145K	-1.47M	4.51M	3.97M	-46K	-26K
Operating Expenses	239.52M	1.7M	173.72M	166.65M	168.39M	144.87M	41.48M	25.11M	15.59M
Interest Expense	9.29M	45.07M	8.9M	1.1M	n/a	n/a	12.67K	n/a	n/a
Selling & Marketing Expenses	n/a	1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	250.91M	196.73M	173.72M	166.65M	168.39M	144.87M	41.48M	25.11M	15.59M
Income Tax Expense	1.53M	-19K	-24.37M	-23.89M	-24.16M	-15.16M	-5.21M	-3.65M	-1.78M
Shares Outstanding (Basic)	255.16M	173.94M	94.99M	72.08M	51.56M	43.07M	31.56M	13.78M	13.78M
Shares Outstanding (Diluted)	255.16M	173.94M	94.99M	72.08M	51.56M	43.07M	31.56M	13.78M	13.78M
EPS (Basic)	-0.86	-1.2	-1.57	-1.97	-2.76	-2.88	-0.99	-1.43	-0.91
EPS (Diluted)	-0.86	-1.2	-1.57	-1.97	-2.76	-2.88	-0.99	-1.43	-0.91
EBITDA	-182.42M	-156.77M	-135.54M	-132.01M	-160.51M	-134.4M	-50.32M	-22.41M	-13.9M
EBIT	-209.84M	-163.34M	-139.66M	-140.93M	-166.26M	-139.01M	-52.03M	-23.42M	-14.38M
Depreciation & Amortization	7.72M	6.57M	7.42M	8.55M	5.75M	4.61M	1.71M	1.01M	478K